Nexus Pharmaceuticals
Roberto Curiel is an accomplished analytical scientist with extensive experience in the pharmaceutical industry. Currently serving as a Senior Lead Analytical Scientist in R&D at Nexus Pharmaceuticals, Inc. since January 2019, Roberto previously held positions including Lead Scientist and Analytical Chemist II within the same company. Prior to Nexus, Roberto worked at AbbVie as an Analytical Scientist II, focusing on development and validation of analytical techniques such as HPLC and GC. Roberto's career includes significant roles at Celgene, Morton Grove Pharmaceuticals, and Pfizer, where responsibilities ranged from developing and validating analytical test methods to collaborating on method transfer studies. Roberto holds a Bachelor of Science degree in Chemistry from Purdue University, earned in 2006.
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow